Skip to main content

Wearable Devices to Unveil GenAI-Powered Intent-Based Interface Platform and Next-Gen Mudra Pro Flagship at AWE 2026

The Company will showcase its hardware-agnostic neural input ecosystem including Mudra Pro and Mudra Studio, and live neural input demonstrations for AI, XR and robotics  YOKNEAM ILLIT, ISRAEL, June 15, 2026 (GLOBE NEWSWIRE) — Wearable Devices Ltd. (Nasdaq: WLDS, WLDSW) (Wearable Devices or the Company), a pioneer in artificial intelligence (“AI”)-powered touchless sensing wearables, today announced its comprehensive lineup for the Augmented World Expo 2026 (AWE 2026). The premier industry conference is set to take place June 15 to 18, 2026, in Long Beach, California, At Booth 648 on the expo floor and in meeting room Hall 201A. As spatial computing and AI agents converge, Wearable Devices is positioning its proprietary neural-input technology as a leading solution for intent-based interfaces. Unlike legacy camera-based motion...

Continue reading

ENDO 2026 Oral Presentation Highlights Comparative Clinical Data for Entera’s Breakthrough Single Tablet EB613 (First-in-Class Oral PTH(1-34) Anabolic for Osteoporosis)

The pharmacokinetic (PK) and pharmacodynamic (PD) profiles of single tablet EB613, multi-tablet EB613 and Forteo® reported for the first time as an oral presentation at ENDO 2026 Single tablet EB613 achieved a comparable PK/PD profile to Forteo® and multi-tablet EB613, which was evaluated in Entera’s Phase 2 study in postmenopausal women with osteoporosis and low bone mass This major scientific achievement supports advancing single tablet EB613 into Entera’s planned Phase 3 study of EB613 in postmenopausal women with osteoporosis TEL AVIV, June 15, 2026 (GLOBE NEWSWIRE) — Entera Bio Ltd. (NASDAQ: ENTX) (“Entera” or the “Company”), a leader in the development of oral peptides, today reported comparative Phase 1 data evaluating single-tablet and multi-tablet oral EB613 with Forteo® (teriparatide SC injection, Eli Lilly). The oral...

Continue reading

Cannabix Technologies Announces Deployment of Marijuana Breath Test (MBT) with Major Industrial Operator in Quebec

VANCOUVER, British Columbia, June 15, 2026 (GLOBE NEWSWIRE) — Cannabix Technologies Inc. (CSE: BLO) (OTCID: BLOZF) (Frankfurt: 8CT) (the “Company” or “Cannabix”) developer of marijuana and alcohol breath testing devices for workplace safety and law enforcement, is pleased to announce deployment of its Marijuana Breath Test (“MBT”) products with a major industrial company operating in the heavy materials sector with significant workforce and operational footprint in Québec. The MBT is being utilized to support workplace safety programs, including post-incident and reasonable-cause testing protocols (see Figure 1). The delivery was completed through Montreal based Alco Prevention Canada. This deployment reflects growing interest for breath-based THC testing solutions in heavy industry, where employers require timely and defensible...

Continue reading

BlockchAIn Announces Corporate Name Change to AIB Data Centers Inc.

New Name Reflects Company’s Strategic Focus on AI and High-Performance Computing Infrastructure NEW YORK, June 15, 2026 (GLOBE NEWSWIRE) — BlockchAIn Digital Infrastructure, Inc. (NYSE American: AIB) (“BlockchAIn” or the “Company”), a developer and operator of digital infrastructure focused on artificial intelligence (“AI”) workloads, today announced that it will change its corporate name to AIB Data Centers Inc., effective June 25, 2026. Trading under the new name will begin on June 26, 2026. The name change reflects the Company’s evolution from its historical roots in digital asset infrastructure toward its current strategy of developing and operating next-generation data center infrastructure designed to support AI, HPC, and other advanced computing applications. The Company’s...

Continue reading

Bond CEO to Host Investor Webinar on New Developments Reinforcing Accelerating Demand

Webinar will be held on June 17, 2026, at 11:00 AM Eastern Time NEW YORK, June 15, 2026 (GLOBE NEWSWIRE) — Our Bond, Inc. (“Bond”) (NASDAQ: OBAI), the creator of the world’s first AI-powered Preventative Personal Security platform adopted by leading multinational companies, today announced that Founder and CEO Doron Kempel will host a live investor webinar on Wednesday, June 17, 2026, at 11:00 AM Eastern Time. Investors and members of the media are encouraged to participate. Mr. Kempel plans to discuss new developments that reinforce Bond’s accelerating momentum. Webinar Details: Date: Wednesday, June 17, 2026Time: 11:00 AM Eastern TimeRegistration Link: https://ourbond.zoom.us/webinar/register/WN_vr-CDAhqRFiuPmf3OqYOlw About Bond Bond is an international company headquartered in New York City — with command centers around...

Continue reading

Regulatory release no. 9 – 2026: Major shareholder announcement

Major shareholder announcement With reference to company announcement no. 4-2026 dated 11 June 2026 related to the results of the initial public offering (the “Offering”) and admission to trading of all of the shares of InstallatørGruppen A/S (“InstallatørGruppen” or the “Company”, and together with its consolidated subsidiaries, the “Group”) to trading on Nasdaq Copenhagen A/S (“Nasdaq Copenhagen”), InstallatørGruppen hereby announces that it has received the following notification pursuant to Section 38 of the Danish Capital Markets Act regarding the direct and indirect holding of shares in the Company by FSN Capital GP VI Limited, acting for itself and in its capacity as general partner or portfolio manager (as applicable) for and on behalf of each of FSN Capital VI L.P., FSN Capital VI Invest L.P. and FSN Capital VI Lux SCSp. The Shares...

Continue reading

HyOrc Corporation Secures Financing for Initial Module of 35 TPD Portuguese Waste-to-Methanol Facility

HOUSTON, June 15, 2026 (GLOBE NEWSWIRE) — HyOrc Corporation (OTCQB: HYOR) today announced it has secured financing for the first module of its 8 Tonnes Per Day (TPD) commercial waste-to-methanol facility in Porto, Portugal. Manufacturing is actively underway for an initial modular unit capable of producing up to 1 TPD of green methanol, targeted for shipment in September 2026. This milestone accelerates HyOrc’s mission to provide decentralized, sovereign energy security. As industrialized nations remain exposed to volatile global supply chains, HyOrc unlocks a massive domestic reserve: legacy Refuse-Derived Fuel (RDF). By converting local waste into competitive green methanol, the company turns an environmental liability into a home-grown strategic fuel. The Porto deployment builds on HyOrc’s proven operational track record, which...

Continue reading

Core AI Holdings Appoints John Clinton Haley Former Meta Leader to Advisory Board

AI Infrastructure leader and Allianca Group CEO brings deep data center development expertise to support Core’s AI infrastructure strategy  MIAMI, FL, June 15, 2026 (GLOBE NEWSWIRE) — Core AI Holdings, Inc. (Nasdaq: CHAI) (“Core AI”), a global AI technology and infrastructure company, today announced the appointment of John Clinton Haley, Co-Founder and Chief Executive Officer of Allianca Group Inc., to its Advisory Board. Haley joins Core AI following the Company’s recently announced strategic joint venture with Allianca, a partnership designed to accelerate the development and delivery of AI-ready data center infrastructure to meet rapidly growing demand for next-generation compute capacity. As Co-Founder and CEO of Allianca Group, Haley has helped oversee the delivery of more than 720 MW of mission-critical...

Continue reading

Auction result of Treasury Bills – RIKV 26 0916 – RIKV 26 1216

Series  RIKV 26 0916 RIKV 26 1216Settlement Date  06/18/2026 06/18/2026Total Amount Allocated (MM)  19,706 18,370All Bids Awarded At (Price / Simple interest)  98.044 / 7.980 96.110 / 8.050Total Number of Bids Received  13 15Total Amount of All Bids Received (MM)  21,706 24,370Total Number of Successful Bids  11 12Number of Bids Allocated in Full  11 12Lowest Price / Highest Simple Interest Allocated  98.044 / 7.980 96.110 / 8.050Highest Price / Lowest Simple Interest Allocated  98.111 / 7.701 96.301 / 7.640Lowest Price / Highest Simple Interest Allocated in Full  98.044 / 7.980 96.110 / 8.050Weighted Average of Successful Bids (Price/Simple Interest)  98.075 / 7.851 96.185 / 7.889Best Bid (Price / Simple Interest)  98.111 / 7.701 96.301 / 7.640Worst Bid (Price / Simple Interest)  98.030 / 8.038 96.068 / 8.141Weighted...

Continue reading

Kraig Biocraft Laboratories CEO Kim Thompson Highlights Commercial Scale, Competitive Advantages, and the Future of Spider Silk in Featured Pulse 2.0 Interview

Company’s Founder Details Production Growth, Industry Transformation Strategy, and Expanding Commercial Opportunities for Recombinant Spider SilkKim ThompsonKim Thompson, Founder and CEO of Kraig Biocraft LaboratoriesANN ARBOR, Mich., June 15, 2026 (GLOBE NEWSWIRE) — Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) (“the Company”, “Kraig Labs”, or “Kraig’s”), a world leader in spider silk technology*, today announced that Founder and Chief Executive Officer Kim Thompson was recently featured in an extensive interview with Pulse 2.0, where he discussed the Company’s technological leadership, commercial production progress, expanding market opportunities, and long-term vision for transforming the global advanced materials industry. The interview comes as Kraig Labs continues...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.